about
Chronic Lung Allograft Dysfunction: A Systematic Review of Mechanisms.Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis.Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept.Biomarkers in the exhaled breath condensate of healthy adults: mapping the path towards reference values.Exhaled breath condensate in patients with asthma: implications for application in clinical practice.Pulmonary biomarkers in COPD exacerbations: a systematic review.Development of a Multivariate Prediction Model for Early-Onset Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome in Lung Transplantation.Safety of Drugs during Pregnancy and Breastfeeding in Cystic Fibrosis Patients.Iatrogenic bleeding during flexible bronchoscopy: risk factors, prophylactic measures and management.Radial Ultrasound-Assisted Transbronchial Biopsy: A New Diagnostic Approach for Non-Resolving Pulmonary Infiltrates in Neutropenic Hemato-Oncological Patients.The acute effect of smoking in healthy and asthmatic smokers.Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds.Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate-gene association study.Airway Microbiota Determines Innate Cell Inflammatory or Tissue Remodeling Profiles in Lung Transplantation.Linear-Endobronchial Ultrasound-Guided Insertion of a Fiducial Marker: A New Tool for Tracking Central Lesions.Systemic and airway inflammation and the presence of emphysema in patients with COPD.Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung.Blood Gene Expression Predicts Bronchiolitis Obliterans Syndrome.Fluoroscopic-Guided Radial Endobronchial Ultrasound Without Guide Sheath For Peripheral Pulmonary Lesions: A Safe And Efficient Combination.Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollen season.Late Major Hemoptysis After Lung Volume Reduction With Coils Induced by Dual Antiaggregation Therapy.A 3-step therapeutic strategy for severe alveolar proteinosis.Polymorphisms and haplotypes in MyD88 are associated with the development of sarcoidosis: a candidate-gene association study.Lung Volume Reduction Coil Treatment: Is There an Indication for Antibiotic Prophylaxis?Complications of valve lung volume reduction in a case of previous pleurodesis.Noninvasive ventilation in chronic respiratory failure: effects on quality of life.One-year non-invasive ventilation in chronic hypercapnic COPD: effect on quality of life.Clinical significance of post-prophylaxis cytomegalovirus infection in lung transplant recipients.Acute Cellular Rejection: Is It Still Relevant?Distinct Genomic Features Characterize Two Clades of : Proposal of Subsp. Subsp. nov. and Subsp. Subsp. novCOLT : 10 ans de recherche en transplantation pulmonaire, résultats et perspectivesExhaled NO and exhaled breath condensate pH in the evaluation of asthma controlPlasma leptin and adiponectin in COPD exacerbations: Associations with inflammatory biomarkersClinical, functional and biochemical changes during recovery from COPD exacerbationsSystemic oxidative stress in patients with pulmonary sarcoidosisSerum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosisDiscrimination of exudative pleural effusions based on multiple biological parametersPerceptions towards physical activity in adult lung transplant recipients with cystic fibrosisRethinking bronchoalveolar lavage in acute cellular rejection: How golden is the standard of transbronchial biopsies?Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis
P50
Q30249868-0DADA723-D515-4FBD-A36F-9DD9A2D41431Q33442068-716DC04D-4752-4342-9AEA-A128CF19F940Q34558555-F26C9477-4150-4A03-9794-3B720746CEA3Q37108400-56710136-C826-42D2-818E-8E5A00253EDBQ37114066-B55A25DE-6A0F-4964-9E11-18B90E090C50Q38154291-98BA1EB9-FE5C-4CD9-8367-63B18CC18CA4Q38645350-711CC901-DF98-4327-88C7-A71D69F02884Q38760587-EDC9552B-4E23-4BAD-B31E-FBE3407A642EQ39401582-0F923686-E128-451F-B3DF-FD56797E3AE9Q40468968-71FB1E54-4C84-4D7F-B7D9-53505FC1E886Q43242657-1362BA3F-FCC3-4D63-83FC-6B891C68D083Q43817131-F47D2FEB-8617-4DB6-81BC-2640EA304DC0Q45888335-7A669723-6C0A-488C-B1D2-7ACA5D8A55DAQ46539385-7F5211B2-F5F5-436F-8BDA-9106D07F1AE0Q47943948-A75BC9C8-405D-40C5-B5A2-178DE54E5930Q48973423-05123E4F-9564-4D24-932D-7DFB08A2B1B7Q49381015-E46FBA55-F4B9-4AD0-8124-9BA2E8DA5205Q49630908-030B636A-19EA-46E1-93DA-723944A49CE9Q50596321-0FEC84CA-A318-4567-B8F5-3A2BD5FE571AQ50881284-EF86A3FD-621F-458B-85E2-3D1DEDC25DA9Q50890946-9740BC3C-F6F2-46A1-8791-BB73F70CFC4BQ50992843-5B3F509C-7E10-4869-B32E-B19A046520F1Q51000613-EDC2718B-0541-495C-A2AE-A218D26CDC98Q51650511-BE07F6BC-79CC-459F-BD1B-2EB1D59F5B0BQ51699417-FF4E4CDF-B81C-4A75-98E4-4DCAD1B76C79Q51848816-C47A2004-6787-4517-B32C-B340B5EDB29FQ51893769-36178513-B6F0-4598-8D99-7DBCEA2640E9Q52617523-B54EC7CB-D73A-40D1-B526-8C38360D8AE0Q52630653-61DA48B6-FAC5-4A5D-8C36-7A30F885D149Q57922300-67BA0EDC-B686-4567-84B4-DB1CB49689EDQ61510585-227F782D-C87C-4BE1-A3BF-3404FE6FC8BBQ61510725-99273F53-2A6D-45B9-97F7-5FCBE425CEDFQ61510753-EB068D4D-3DDC-44E1-9AD8-3E0C0E8960B0Q61510783-EBA74660-CC07-4C1E-B863-48C67F9FBD39Q61510819-55115873-1614-4BA6-B88B-1D62DEE46F5EQ61510854-E0EA77E8-5DEC-4B5D-93C8-1F6B2A9A0DE6Q61510857-2AA05E72-8AEC-4043-9221-DAF0EC153455Q89830974-7C0DB8C2-61C2-4663-8E66-EFC8BCED040DQ92229094-E9530DB3-C62C-447D-A88F-4F72ED69D23FQ92574884-3EECA216-BFB7-4B96-A6E4-87A17FD0E5BC
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Angela Koutsokera
@ast
Angela Koutsokera
@en
Angela Koutsokera
@es
Angela Koutsokera
@nl
Angela Koutsokera
@sl
type
label
Angela Koutsokera
@ast
Angela Koutsokera
@en
Angela Koutsokera
@es
Angela Koutsokera
@nl
Angela Koutsokera
@sl
prefLabel
Angela Koutsokera
@ast
Angela Koutsokera
@en
Angela Koutsokera
@es
Angela Koutsokera
@nl
Angela Koutsokera
@sl
P106
P21
P31
P496
0000-0003-1227-1679